The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Related Articles
Adjuvant Chemotherapy After Resection of Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX
This cohort study investigates the association of adjuvant chemotherapy following resection of pancreatic adenocarcinoma after preoperative FOLFIRINOX in full or modified dosing with overall survival,…
Maintenance Galinpepimut-S Appears Effective and Safe in AML in Second CR
Galinpepimut-S demonstrated early efficacy signals in patients with acute myeloid leukemia in second complete remission or later.
Tagitanlimab Plus Chemotherapy Receives Chinese Approval for Recurrent/Metastatic Nasopharyngeal Cancer
Tagitanlimab received marketing authorization from the Chinese NMPA for use with cisplatin and gemcitabine for patients with recurrent or metastatic NPC.
Case Study4
Wolters Kluwer (“we” or “us”) wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain…
Oncology Experts Preview Top Abstracts to be Shared at 2025 ASCO GI
Tanios S. Bekaii-Saab, MD, and Yelena Y. Janjigian, MD, preview top presentations from this year’s Gastrointestinal Cancers Symposium.
Association of mental health treatment receipt with cancer screening among US adults with a history of anxiety or depression
Adults with a history of depression or anxiety who lacked mental health treatment in the past year were significantly less likely to be up-to-date with…
Immunotherapy for pediatric osteosarcoma with lung metastases after resection shows positive data – The Cancer Letter
OS Therapies Inc. announced positive data from a phase IIb clinical trial (NCT04974008) of OST-HER2 (OST31-164)—the company’s HER2-targeted immunotherapy candidate in the rare pediatric-designated indication…
The common VTE-protective G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding
Key PointsIndividuals homozygous for the F5 G haplotype (F5-G/G) have increased alternative F5 splicing that leads to increased plasma FV-short levels.F5-G
January 2025 | ASH Clinical News | American Society of Hematology
January 2025 | ASH Clinical News | American Society of Hematology January 2025 Health Care Handcuffed? The overturning of the Chevron doctrine, a decades-old precedent,…
Enhanced Dermatologic Care Reduced AEs from MARIPOSA Regimen in NSCLC
Doxycycline/minocycline, clindamycin, chlorhexidine, and a ceramides-based noncomedogenic moisturizer reduced skin- and nail-related AEs in NSCLC.
